BioSpace News Archive

Genetown

JAMA Paper Withdrawal Adds One More Layer to Aduhelm Controversy

Biogen reportedly withdrew a paper it had submitted to the medical journal JAMA after the publication requested edits before publication. It’s standard for a technical journal to request edits, but it is the nature of the edits—and in this case, the nature of the study— that raises questions.

July 28, 2021
·
3 min read
·
Mark Terry
Medical Beds Market: Increasing Prevalence of Chronic Diseases to Drive Global Market Growth.

The medical beds market was valued at US$ 3,580.52 million in 2018 and it is projected to reach US$ 5,710.7 million in 2027; it is expected to grow at a CAGR of 5.4% from 2019 to 2027.

July 28, 2021
·
4 min read
Job Trends

Deep Genomics is Rewriting RNA for Powerful Therapeutics with $180M Series C

“For the first time in history, medicine has become information.” That’s the groundbreaking connection AI-driven RNA therapeutics has given us, according to Deep Genomics Founder and CEO Brendan Frey.

July 28, 2021
·
3 min read
·
Kate Goodwin
Drug Development

Emerging Drug-Resistant Fungi Threat Offset by Cidara’s Phase III Antifungal Therapy

The FDA Watch List considers drug-resistant Candida auris (C. auris) an urgent threat, drug-resistant Candida species a serious threat, and azole-resistant Aspergillus Fumigatus worth watching – especially since person-to-person transmission of drug-resistant fungi has been recently documented.

July 28, 2021
·
4 min read
·
Gail Dutton
Deals

$2.5B Teneobio Deal Complements Amgen’s Core and Capabilities

Amgen will gain Teneobio’s proprietary bispecific and multispecific antibody technologies, which have the potential to target multiple diseases across Amgen’s core therapeutic areas.

July 28, 2021
·
3 min read
·
Alex Keown
Drug Development

GSK Posts Strong Q2 as it Moves toward 2022 Demerger

The company’s pipeline was strengthened in the second quarter with three strategic collaborations in immuno-oncology, immuno-neurology, and HIV.

July 28, 2021
·
3 min read
·
Alex Keown
Biotech Bay

Money on the Move: July 21 – 27, 2021

A quick overview of life science companies scooping up some summer spending money this week.

July 28, 2021
·
3 min read
·
Kate Goodwin
Job Trends

Life Sciences Companies Throwing Money into Facility Expansions and Jobs

There has been a flurry of expansion activity in the life sciences industry as biopharma and diagnostic companies expand manufacturing sites. Here’s a look.

July 28, 2021
·
4 min read
·
Mark Terry
Business

DA32 Life Science SPAC Prices $200M IPO

Deerfield Management and ARCH Venture Partners have partnered with venture capital firm Section 32 to sponsor DA32 Life Science Tech Acquisition Corp, a blank check company that is today priced for $200 million in an initial public offering (IPO).

July 28, 2021
·
2 min read
·
Brandon May
Business

Global Roundup: Takeda and PeptiDream Expand CNS Collaboration

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations including Takeda, Origin Therapeutics, ERS Genomics and more.

July 28, 2021
·
6 min read
·
Alex Keown